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Abstract
Purpose: To evaluate the safety and the effectiveness of CO2
splenoportography with the “skinny” needle.
Methods: A flexible, 22 gauge needle (“skinny” needle) was
introduced into the exteriorized spleens of five pigs. After
checking the intrasplenic positioning with CO2 injection,
increasing doses of CO2 (10–60 cm
3) were injected using a
dedicated CO2 injector with digital imaging. The puncture
sites were observed during and after CO2 injections, and
after removal of the needle. The spleens were then removed
for gross and microscopic examination.
Results: In all animals digital subtraction CO2 splenoporto-
grams showed the splenic, extra- and intrahepatic portal
veins, and the most distal portion of the superior mesenteric
vein. No CO2 extravasation occurred in the spleen. There
was no significant bleeding from the puncture site after
removal of the needle. Gross and microscopic examination
revealed no evidence of splenic rupture or intrasplenic he-
matoma.
Conclusion: CO2 splenoportography with the “skinny” nee-
dle is a safe and simple method of visualizing the portal vein
and its branches. Careful appraisals of the clinical usefulness
of the method will be needed in various clinical settings.
Key words: Splenoportography—Carbon dioxide—Skinny
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Since the reports in 1951 that the portal vein could be
visualized by intrasplenic injection of contrast material, sple-
noportography has been used for evaluation of patients with
cirrhosis and portal hypertension, before and after portosys-
temic shunt surgery [1–8]. The procedure involves percuta-
neous introduction of a needle (16 to 22 gauge) into the
spleen and intrasplenic injection of 24–30 cm3 of contrast
material in 4–5 sec [5, 6, 8]. Although the method was
proven to be safe and effective, it has been replaced by
arterial portography (visualization of the portal vein and its
branches by intra-arterial injection of contrast material) and
noninvasive imaging methods (ultrasound, computed tomog-
raphy, and magnetic resonance venography).
Recently a 2-year-old female underwent a successful,
uncomplicated CO2 splenoportogram using a 22 gauge
“skinny” needle after unsuccessful visualization of the portal
vein by noninvasive imaging methods. She was a candidate
for liver transplantation for liver failure secondary to biliary
atresia. This experimental study was undertaken in swine to
examine the safety and effectiveness of CO2 splenoportog-
raphy using the “skinny” needle.
Materials and Methods
Five pigs (25–35 kg) were anesthetized with intramuscular injec-
tion of ketamine (35 mg/kg) followed by halothane. The trachea
was cannulated low in the neck and the lungs were ventilated with
30% oxygen in air on a mechanical ventilator. The abdomen was
opened in the midline and the spleen was exteriorized and placed
outside the abdominal cavity (Fig. 1). A flexible, 10 cm long, 22
gauge needle (0.5 mm inner diameter, 0.7 mm outer diameter;
Cook, Bloomington, IN, USA) was used to puncture the spleen.
Digital subtraction angiography (DSA) with a 5 cm3 CO2 injection
was used to check the positioning, and the needle was connected to
a dedicated CO2 injector (AngioDynamics, Queensbury, NY,
USA). CO2 was injected at the rate of 5, 10, 20, and 30 cm
3/sec for
2 sec and digital subtraction images were obtained at the rate of 4
exposures/sec using a Mobile Digital Imaging System (OEC Med-
ical Systems, Salt Lake City, Utah, USA). CO2 injections were
separated by 5 min. The spleens were observed during and after
CO2 injections.
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After completion of CO2 injections in each animal, the needle
was removed, and the puncture site was checked for evidence of
bleeding for 30 min. All animals were killed, and the spleens were
removed. Serial sections were made through the areas of punctures
sites. Random sections of the spleens were fixed in 10% buffered
formalin for microscopic examination. All images were evaluated
for the quality of splenoportograms.
Results
All animals survived the experimental period. No complica-
tions occurred. Vital signs and SaO2 remained stable after
CO2 injections. The spleens appeared unremarkable during
and after CO2 injections. After removal of the needle, a small
amount of venous bleeding occurred from the puncture site,
which ceased spontaneously in 3–5 min.
All digital subtraction CO2 splenoportograms showed the
portal vein and its branches. There was no evidence of CO2
extravasation at the injection site (Fig. 2). The intrahepatic
portal branches filled to the periphery of the liver, but no
hepatogram was seen. CO2 disappeared from the portal vein
gradually over 2–3 min. Visualization of the portal vein
improved with increasing injection doses of CO2. The entire
portal venous system filled when injected with 20 cm3/sec
for a total volume of 40 cm3. Neither the hepatic vein nor the
inferior vena cava was visualized. The superior mesenteric
vein was opacified due to reflux of the gas.
Grossly, the spleens were normal. There was no evidence
of subcapsular dissection or intrasplenic hematoma (Fig. 3).
Microscopically, the splenic capsule was intact and there
was no subcapsular hematoma.
Discussion
For years splenoportography was used to obtain the ana-
tomic and hemodynamic information necessary for the diag-
nosis and treatment of patients with cirrhosis and portal
hypertension in both adult and pediatric age groups [9–12].
Many reports have described the safety and usefulness of the
method in visualizing the portal vein and its branches as well
as the portosystemic collateral veins [5, 7, 9, 13]. When the
spleen is successfully punctured, a contrast injection predict-
ably opacifies the portal vein and its branches. Despite the
advantages of the procedure, it has become a very infre-
quently used angiographic method. This can in part be at-
tributed to the risk of bleeding related to the splenic
puncture, fear by most physicians concerning the fragility of
the splenic capsule, and the advent of arterial portography
and noninvasive imaging methods. It seems that general
unawareness of the technique and inexperience with spleno-
portography will further reduce the use of the method.
Although the technique of CO2 splenoportography is sim-
ilar to those of traditional procedures [2, 5, 6, 12], it has
some advantages. The most significant of these is the safety
of the procedure. This can be ascribed to the use of the
“skinny” needle to puncture the spleen and to the use of CO2
as a contrast agent. The safety of using the “skinny” needle
has been well documented in percutaneous transhepatic
cholangiography, percutaneous biopsy, and other organ ac-
cess procedures [14, 15]. Unlike contrast material, the intra-
splenic injection of CO2 does not cause extravasation
because of the low viscosity of the gas. The “skinny” needle
allows injection of large quantities of CO2 into the spleen.
When contrast material is used for splenoportography, dilute
contrast should be used at a lower rate [6, 8]. One disadvan-
tage of the use of the “skinny” needle is the inability to
measure the splenic pulp pressure, as blood would not return
through the needle.
CO2 splenoportography seems to be safe enough for
clinical applications, considering the fact that splenic hem-
Fig. 1. Photograph of an exteriorized spleen (s) with a 22
gauge needle (arrow) introduced into its lower pole.
Fig. 2. Digital subtraction splenoportogram with the injec-
tion of CO2 at 10 ml/sec for 2 sec shows opacification of the
splenic (sv) and portal (PV) veins, and intrahepatic portal
venous branches. There is reflux of CO2 into the superior
mesenteric vein (arrow). The asterisk indicates the tip of the
needle and CO2 injection site in the spleen.
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orrhage did not occur following multiple intrasplenic injec-
tions of the gas at quantities more than sufficient for portal
vein opacification. Thoughtful appraisals of the clinical use-
fulness of the method should be undertaken in various clin-
ical settings. These may include evaluation of patients with
cirrhosis and portal hypertension, prior to hepatic transplan-
tation, evaluation of the resectability of pancreatic and bili-
ary neoplasms, and visualization of the portal vein during
TIPS procedures.
CO2 is a useful alternative contrast agent for arterial and
venous examinations in patients with hypersensitivity to
iodinated contrast material and compromised renal function
[16]. CO2 has several unique physical properties that are
important in CO2 angiography. These include solubility,
viscosity, buoyancy, and compressibility. CO2 is at least 20
times more soluble than air, allowing an intravascular injec-
tion without causing clinically significant gas embolism.
Proper use of the hand-held syringe and the plastic bag
system [17] will minimize the risk of air contamination. The
low viscosity of the gas is the primary reason for the safety
of CO2 splenoportography. It allows intrasplenic injection
using the “skinny” needle, such as a 22 or a 25 gauge needle.
Multiple injections can be made manually or using a dedi-
cated CO2 injector without the risk of bleeding or splenic
laceration. Resistance to gas flow through the needle usually
results in compression of the gas, and sudden expansion
occurs upon exiting the needle. This is known as “explosive”
delivery. However, we found no evidence of extravasation or
splenic injury despite manual injections of large amounts of
CO2 into the splenic pulp.
Since the red pulp accounts for three-quarters of the
volume of the human spleen, which comprises arteries, ve-
nous sinuses, and pulp veins, the needle tip seemed to be in
a vascular space when introduced. When CO2 was injected,
the gas bubbles coalesced rapidly into larger bubbles filling
the splenic and portal veins. There was no evidence of CO2
extravasation at the injection site. The portal vein and its
branches filled well because of the anterior location relative
to the spleen. Understanding of the buoyancy of CO2 is
important, as the portal vein would be filled with CO2
regardless of the direction of the venous blood flow in the
portal venous system. In other words, the portal vein could
be visualized with CO2 in the presence of reversal of flow in
the portal vein. In a canine experimental study, Hipona and
Park [18] demonstrated much better filling of the portal vein
and its intrahepatic branches with intrasplenic injections of
CO2 in the left posterior oblique position.
On the basis of this experimental study and our clinical
experience with a pediatric patient, the following technique
for CO2 splenoportography is suggested. Preangiographic
preparation of a patient for CO2 splenoportography should
be the same as for conventional angiography and percutane-
ous fine needle biopsy. To reduce bleeding from the puncture
site, clotting abnormalities should be corrected. Ascites is
not an absolute contraindication to splenoportography but
attempts should be made to relieve ascites prior to the
procedure. The procedure can be done with mild sedation;
general anesthesia may be required in pediatric patients. The
spleen can be punctured accurately under ultrasound guid-
ance. When the needle is introduced into the spleen, a 5 cm3
CO2 injection is made, and imaged with digital subtraction
technique to check the positioning. When the needle is
properly located in the spleen, the splenic and portal veins
should be opacified. The quantities and injection rates should
vary, depending upon the clinical problem and the size of the
portal vein and portosystemic collateral veins. In pediatric
patients, 10–15 cm3 of CO2 will fill the portal vein and its
branches. Larger quantities of CO2 may be required to op-
timally visualize the portal vein and its branches in adults.
In summary, CO2 is a safe and effective contrast agent for
splenoportography with the benefit of low viscosity that
allows injection through the “skinny” needle, thus reducing
the risk of postprocedural bleeding. The method warrants
further clinical evaluation of its diagnostic usefulness in
various settings including evaluation of patients with cirrho-
sis and portal hypertension, variceal bleeding, portal vein
Fig. 3. A, B. Gross photograph of the spleen after CO2 splenoportography. A The spleen appears normal with an intact
splenic capsule. B Sections through the injection site show no intrasplenic hematoma.
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visualization prior to a TIPS procedure, portosystemic shunt
procedure and liver transplantation candidates, suspected
portal or splenic vein occlusion, and preoperative evaluation
of resectability of biliary and pancreatic neoplasms.
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